imperatorin has been researched along with Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, H; He, J; He, L; Wang, T; Zhang, Y; Zhou, N | 1 |
1 other study(ies) available for imperatorin and Hyperplasia
Article | Year |
---|---|
The imperatorin derivative OW1, a new vasoactive compound, inhibits VSMC proliferation and extracellular matrix hyperplasia.
Topics: Actins; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Calcium Channels; Cell Proliferation; Collagen Type I; Collagen Type III; Extracellular Matrix; Furocoumarins; Hyperplasia; Hypertension, Renovascular; Male; Matrix Metalloproteinases; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley | 2015 |